EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients
- Status
- SUSPENDED
- Phase
- PHASE2
Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin
- Status
- WITHDRAWN
- Phase
- PHASE2
Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)
- Status
- COMPLETED
- Phase
- PHASE3
Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural Effusion
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
- Status
- TERMINATED
- Phase
- PHASE3
Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
- Status
- COMPLETED
- Phase
- PHASE1